NIH-funded research R01 grant

How faulty cholesterol control in pancreas cells can cause pancreatitis

Official title: Dysregulated cholesterol homeostasis, caused by lysosomal/autophagy dysfunction, mediates pancreatitis

Funded at University of California Los Angeles · NIH-11245716 · Data updated 2026-11-12

This project explores whether problems with cell cleanup in the pancreas lead to cholesterol buildup in pancreas cells and trigger acute pancreatitis.

More Pancreatitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startApril 1, 2023
Project endDecember 31, 2027
Funding year2026
Award (this year)$354,816
NIH project number5R01DK131493-04
Project IDNIH-11245716 on NIH RePORTER

Who could benefit from this research

Could help

People who have had recent acute pancreatitis attacks or are considered at high risk for acute pancreatitis would be the most relevant candidates to benefit or to provide samples.

Less likely to help

People without pancreas disease or whose pancreatitis is clearly driven by unrelated causes (for example, obstructing gallstones or heavy alcohol use) may not benefit directly from these findings.

What this research studies

From my perspective as a patient, the team will use lab-grown pancreas cells and mouse models to see how failures in the cell 'cleanup' system (lysosomes and autophagy) change how cholesterol is handled. They will examine human pancreas tissue or clinical data where available to connect those lab findings to people with pancreatitis. The researchers will test whether cholesterol-lowering drugs like statins affect cell damage, mitochondrial stress, and the harmful responses seen in pancreatitis. Together these approaches aim to show whether fixing cholesterol handling in pancreas cells could prevent or lessen pancreatitis attacks.

Why it matters

Potential benefit: If successful, this work could point to cholesterol-focused treatments (including repurposing statins) or new drug targets to prevent or reduce acute pancreatitis.

How similar studies have gone: Previous animal studies link autophagy problems to pancreatitis and some epidemiologic research associates statin use with lower pancreatitis rates, but directly connecting pancreatic cholesterol handling to disease is a newer, less-tested idea.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Gukovskaya, Anna S. — University of California Los Angeles
  • Study coordinator: Gukovskaya, Anna S.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.